Gene · 538
Papers3,096
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 3,096
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive multiomics analysis of cuproptosis-related gene characteristics in hepatocellular carcinoma. | Front Genet | 2022 | 36147507 | PubTator, text mining | PubMed |
| Integration of Bulk and Single-Cell RNA-Seq Data to Construct a Prognostic Model of Membrane Tension-Related Genes for Colon Cancer. | Vaccines (Basel) | 2022 | 36146640 | PubTator, text mining | PubMed |
| Role of Trientine in Hypertrophic Cardiomyopathy: A Review of Mechanistic Aspects. | Pharmaceuticals (Basel) | 2022 | 36145368 | PubTator, text mining | PubMed |
| Green Tea Catechins: Nature's Way of Preventing and Treating Cancer. | Int J Mol Sci | 2022 | 36142616 | PubTator, text mining | PubMed |
| Whole-Transcriptome Sequencing Analyses of Nuclear Antixoxidant-1 in Endothelial Cells: Role in Inflammation and Atherosclerosis. | Cells | 2022 | 36139494 | PubTator, text mining | PubMed |
| Molecular characteristics, clinical significance, and cancer immune interactions of cuproptosis and ferroptosis-associated genes in colorectal cancer. | Front Oncol | 2022 | 36132144 | PubTator, text mining | PubMed |
| Case report: Huppke-Brendel syndrome in an adult, mistaken for and treated as Wilson disease for 25 years. | Front Neurol | 2022 | 36119696 | PubTator, text mining | PubMed |
| Cuproptosis scoring model predicts overall survival and assists in immunotherapeutic decision making in pancreatic carcinoma. | Front Genet | 2022 | 36118866 | PubTator, text mining | PubMed |
| Whole-exome sequencing reveals PSEN1 and ATP7B combined variants as a possible cause of early-onset Lewy body dementia: a case study of genotype-phenotype correlation. | Neurogenetics | 2022 | 36114914 | PubTator, text mining | PubMed |
| A Novel Cuprotosis-Related Gene FDX1 Signature for Overall Survival Prediction in Clear Cell Renal Cell Carcinoma Patients. | Biomed Res Int | 2022 | 36105937 | PubTator, text mining | PubMed |
| Exposure of metal toxicity in Alzheimer's disease: An extensive review. | Front Pharmacol | 2022 | 36105221 | PubTator, text mining | PubMed |
| A novel prognostic signature based on cuproptosis-related lncRNA mining in colorectal cancer. | Front Genet | 2022 | 36105091 | PubTator, text mining | PubMed |
| A novel cuproptosis-related gene signature for predicting prognosis in cervical cancer. | Front Genet | 2022 | 36092887 | PubTator, text mining | PubMed |
| Case Report: Identification of a novel CASK missense variant in a Chinese family with MICPCH. | Front Genet | 2022 | 36092876 | PubTator, text mining | PubMed |
| Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy. | J Exp Clin Cancer Res | 2022 | 36089608 | PubTator, text mining | PubMed |
| Preparation of Mn/Zn@PG Catalyst for Catalytic Oxidation Treatment of Coal Chemical Wastewater. | Int J Environ Res Public Health | 2022 | 36078522 | PubTator, text mining | PubMed |
| Novel AR/AR-V7 and Mnk1/2 Degrader, VNPP433-3β: Molecular Mechanisms of Action and Efficacy in AR-Overexpressing Castration Resistant Prostate Cancer In Vitro and In Vivo Models. | Cells | 2022 | 36078112 | PubTator, text mining | PubMed |
| Genomic and Epigenomic Characterization of Tumor Organoid Models. | Cancers (Basel) | 2022 | 36077628 | PubTator, text mining | PubMed |
| Copper Modulates Adult Neurogenesis in Brain Subventricular Zone. | Int J Mol Sci | 2022 | 36077284 | PubTator, text mining | PubMed |
| Memo1 binds reduced copper ions, interacts with copper chaperone Atox1, and protects against copper-mediated redox activity in vitro. | Proc Natl Acad Sci U S A | 2022 | 36067318 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/538/papers?page=38